Show simple item record

dc.contributor.authorArndt, Kevin Richarden_US
dc.date.accessioned2016-03-01T18:29:47Z
dc.date.available2016-03-01T18:29:47Z
dc.date.issued2014
dc.identifier.urihttps://hdl.handle.net/2144/14663
dc.description.abstractPrior work demonstrated that impairments in fine motor function produced by a controlled ischemic lesion in monkey primary motor cortex were ameliorated by treatment with a cell drug product, CNTO 0007. This drug contains human umbilical tissue-derived cells, in a proprietary thaw and inject formulation. Brain tissue sections from subjects with and without CNTO 0007 therapy were processed immunohistochemically to identify neurons expressing c-Fos as a marker for neuronal activity. Neurons expressing c-Fos were quantified using unbiased stereology. The number of c-Fos positive neurons in dorsal pre-motor cortex ipsilateral to the lesion were greater in treated animals but only approached statistical significance. These findings suggest that cortical reorganization in the dorsal pre-motor cortex may underlie the observed functional recovery. However, c-Fos expressing neurons in other motor areas, such as the ventral pre-motor cortex, remain to be studied.en_US
dc.language.isoen_US
dc.subjectNeurosciencesen_US
dc.subjectc-Fosen_US
dc.subjectIschemiaen_US
dc.subjectMonkeyen_US
dc.subjectStrokeen_US
dc.titleInvestigating reorganization of the motor cortices following stem cell therapy in a non-human primate model of cortical ischemiaen_US
dc.typeThesis/Dissertationen_US
dc.date.updated2016-01-22T18:57:11Z
etd.degree.nameMaster of Scienceen_US
etd.degree.levelmastersen_US
etd.degree.disciplineAnatomy & Neurobiologyen_US
etd.degree.grantorBoston Universityen_US


This item appears in the following Collection(s)

Show simple item record